InspireMD, Inc. (NSPR)
NASDAQ: NSPR · Real-Time Price · USD
2.350
+0.010 (0.43%)
Oct 21, 2025, 4:00 PM EDT - Market closed
InspireMD Market Cap
InspireMD has a market cap or net worth of $98.04 million as of October 22, 2025. Its market cap has increased by 43.34% in one year.
Market Cap
98.04M
Enterprise Value
82.09M
1-Year Change
43.34%
Ranking
Category
Stock Price
$2.35
Market Cap Chart
Since April 12, 2011, InspireMD's market cap has increased from $54.90M to $98.04M, an increase of 78.59%. That is a compound annual growth rate of 4.07%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 20, 2025 | 97.60M | 42.27% |
Dec 31, 2024 | 68.60M | 13.20% |
Dec 29, 2023 | 60.60M | 741.67% |
Dec 30, 2022 | 7.20M | -70.49% |
Dec 31, 2021 | 24.40M | 93.65% |
Dec 31, 2020 | 12.60M | 223.08% |
Dec 31, 2019 | 3.90M | -35.00% |
Dec 31, 2018 | 6.00M | 500.00% |
Dec 29, 2017 | 1.00M | -72.22% |
Dec 30, 2016 | 3.60M | -47.83% |
Dec 31, 2015 | 6.90M | -77.45% |
Dec 31, 2014 | 30.60M | -62.08% |
Dec 31, 2013 | 80.70M | 5.08% |
Dec 31, 2012 | 76.80M | -32.93% |
Dec 30, 2011 | 114.50M | 108.56% |
Apr 12, 2011 | 54.90M | - |
View and export this data all the way back to 2011. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 717.80B |
Johnson & Johnson | 462.11B |
AbbVie | 408.76B |
UnitedHealth Group | 330.91B |
AstraZeneca | 259.08B |
Novartis AG | 254.71B |
Novo Nordisk | 245.28B |
Abbott Laboratories | 221.98B |